|
Neuropathology
Citations 91-100 of 161 total displayed.
|
Past content
(since Feb 1998):
|
- Original Contributions
Cerebrospinal Fluid Tau Protein and Periventricular White Matter Lesions in Patients With Mild Cognitive Impairment: Implications for 2 Major Pathways
- Masahiro Maruyama; Toshifumi Matsui; Haruko Tanji; Miyako Nemoto; Naoki Tomita; Mari Ootsuki; Hiroyuki Arai; Hidetada Sasaki
Arch Neurol 2004; 61: 716-720.
[Abstract]
[Full text]
[PDF]
- Observations
Copper Perturbation in 2 Monozygotic Twins Discordant for Degree of Cognitive Impairment
- Rosanna Squitti; Emanuele Cassetta; Gloria Dal Forno; Domenico Lupoi; Giulia Lippolis; Flavia Pauri; Fabrizio Vernieri; Antonella Cappa; Paolo M. Rossini
Arch Neurol 2004; 61: 738-743.
[Abstract]
[Full text]
[PDF]
- Observations
Pathologic Prion Protein Spreading in the Peripheral Nervous System of a Patient With Sporadic Creutzfeldt-Jakob Disease
- Alexandre Favereaux; Isabelle Quadrio; Claude Vital; Armand Perret-Liaudet; Olivier Anne; Jean-Louis Laplanche; Klaus G. Petry; Anne Vital
Arch Neurol 2004; 61: 747-750.
[Abstract]
[Full text]
[PDF]
- Neurological Reviews
Paraneoplastic Neurologic Disorders: Windows Into Neuronal Function and Tumor Immunity
- Robert B. Darnell
Arch Neurol 2004; 61: 30-32.
[Extract]
[Full text]
[PDF]
- Original Contributions
Idiopathic Autonomic Neuropathy: Comparison of Cases Seropositive and Seronegative for Ganglionic Acetylcholine Receptor Antibody
- Paola Sandroni; Steven Vernino; Caroline M. Klein; Vanda A. Lennon; Lisa Benrud-Larson; David Sletten; Phillip A. Low
Arch Neurol 2004; 61: 44-48.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting A Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial
- Craig W. Ritchie; Ashley I. Bush; Andrew Mackinnon; Steve Macfarlane; Maree Mastwyk; Lachlan MacGregor; Lyn Kiers; Robert Cherny; Qiao-Xin Li; Amanda Tammer; Darryl Carrington; Christine Mavros; Irene Volitakis; Michel Xilinas; David Ames; Stephen Davis; Konrad Beyreuther; Rudolph E. Tanzi; Colin L. Masters
Arch Neurol 2003; 60: 1685-1691.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Cerebrospinal Fluid Tau and -Amyloid: How Well Do These Biomarkers Reflect Autopsy-Confirmed Dementia Diagnoses?
- Christopher M. Clark; Sharon Xie; Jesse Chittams; Douglas Ewbank; Elaine Peskind; Douglas Galasko; John C. Morris; Daniel W. McKeel Jr; Martin Farlow; Sharon L. Weitlauf; Joseph Quinn; Jeffrey Kaye; David Knopman; Hiroyuki Arai; Rachelle S. Doody; Charles DeCarli; Susan Leight; Virginia M.-Y. Lee; John Q. Trojanowski
Arch Neurol 2003; 60: 1696-1702.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Platelet Amyloid Precursor Protein Abnormalities in Mild Cognitive Impairment Predict Conversion to Dementia of Alzheimer Type: A 2-Year Follow-up Study
- Barbara Borroni; Francesca Colciaghi; Carlo Caltagirone; Luca Rozzini; Laura Broglio; Flaminio Cattabeni; Monica Di Luca; Alessandro Padovani
Arch Neurol 2003; 60: 1740-1744.
[Abstract]
[Full text]
[PDF]
- Observations
Symmetric Deep Cerebellar Lesions After Smoking Heroin
- Allan H. Ropper; Richard Blair
Arch Neurol 2003; 60: 1605-1606.
[Abstract]
[Full text]
[PDF]
- Observations
Cerebral Cavernous Malformations With Dynamic and Progressive Course: Correlation Study With Vascular Endothelial Growth Factor
- Keun-Hwa Jung; Kon Chu; Sang-Wuk Jeong; Hee-Kwon Park; Hee-Joon Bae; Byung-Woo Yoon
Arch Neurol 2003; 60: 1613-1618.
[Abstract]
[Full text]
[PDF]
|
|
